Palisade Bio Stock Alpha and Beta Analysis

PALI Stock  USD 2.46  0.04  1.65%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Palisade Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Palisade Bio over a specified time horizon. Remember, high Palisade Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Palisade Bio's market risk premium analysis include:
Beta
(0.73)
Alpha
(0.36)
Risk
4.87
Sharpe Ratio
(0.11)
Expected Return
(0.52)
Please note that although Palisade Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Palisade Bio did 0.36  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Palisade Bio stock's relative risk over its benchmark. Palisade Bio has a beta of 0.73  . As returns on the market increase, returns on owning Palisade Bio are expected to decrease at a much lower rate. During the bear market, Palisade Bio is likely to outperform the market. As of now, Palisade Bio's Enterprise Value Over EBITDA is increasing as compared to previous years. The Palisade Bio's current Enterprise Value Multiple is estimated to increase to 0.69, while Book Value Per Share is projected to decrease to 23.57.

Enterprise Value

(8.77 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Palisade Bio Backtesting, Palisade Bio Valuation, Palisade Bio Correlation, Palisade Bio Hype Analysis, Palisade Bio Volatility, Palisade Bio History and analyze Palisade Bio Performance.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Palisade Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Palisade Bio market risk premium is the additional return an investor will receive from holding Palisade Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Palisade Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Palisade Bio's performance over market.
α-0.36   β-0.73

Palisade Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Palisade Bio's Buy-and-hold return. Our buy-and-hold chart shows how Palisade Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Palisade Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Palisade Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Palisade Bio shares will generate the highest return on investment. By understating and applying Palisade Bio stock market price indicators, traders can identify Palisade Bio position entry and exit signals to maximize returns.

Palisade Bio Return and Market Media

The median price of Palisade Bio for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 3.45 with a coefficient of variation of 16.48. The daily time series for the period is distributed with a sample standard deviation of 0.53, arithmetic mean of 3.24, and mean deviation of 0.47. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis
09/25/2024
2
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis
10/10/2024
3
Acquisition by Diaz Stephanie of 9580 shares of Palisade Bio at 1.6 subject to Rule 16b-3
10/23/2024
4
ARMISTICE CAPITAL, LLC Acquires Shares in Palisade Bio Inc - GuruFocus.com
11/14/2024
5
Disposition of 4558 shares by Jones Mitchell Lawrence of Palisade Bio subject to Rule 16b-3
11/18/2024
6
Brookline Capital Initiates Coverage of Palisade Bio with Buy Recommendation - MSN
11/20/2024
7
Palisade Bio Now Covered by Brookline Capital Management
11/22/2024

About Palisade Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Palisade or other stocks. Alpha measures the amount that position in Palisade Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Graham Number6.4K122.7116.57
Receivables Turnover1.691.941.85

Palisade Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Palisade Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Palisade Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Palisade Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Palisade Bio. Please utilize our Beneish M Score to check the likelihood of Palisade Bio's management manipulating its earnings.
27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Palisade Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
Check out Palisade Bio Backtesting, Palisade Bio Valuation, Palisade Bio Correlation, Palisade Bio Hype Analysis, Palisade Bio Volatility, Palisade Bio History and analyze Palisade Bio Performance.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Palisade Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Palisade Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Palisade Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...